D. Griffith, R. Thomson, D. Addrizzo-Harris, S. Field, J. Ingen, R. Wallace, C. Coulter, K. Mange, J. Nezamis, K. Winthrop
{"title":"在CONVERT研究中,接受阿米卡星脂质体吸入混悬液(ALIS)治疗难愈鸟分枝杆菌复杂肺病(MAC-LD)患者培养转化的可持续性和持久性","authors":"D. Griffith, R. Thomson, D. Addrizzo-Harris, S. Field, J. Ingen, R. Wallace, C. Coulter, K. Mange, J. Nezamis, K. Winthrop","doi":"10.1164/AJRCCM-CONFERENCE.2019.199.1_MEETINGABSTRACTS.A7359","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":203218,"journal":{"name":"B14. LATE BREAKING CLINICAL TRIALS","volume":"117 18 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":"{\"title\":\"Sustainability and Durability of Culture Conversion in Patients Receiving Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Mycobacterium Avium Complex Lung Disease (MAC-LD) in the CONVERT Study\",\"authors\":\"D. Griffith, R. Thomson, D. Addrizzo-Harris, S. Field, J. Ingen, R. Wallace, C. Coulter, K. Mange, J. Nezamis, K. Winthrop\",\"doi\":\"10.1164/AJRCCM-CONFERENCE.2019.199.1_MEETINGABSTRACTS.A7359\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":203218,\"journal\":{\"name\":\"B14. LATE BREAKING CLINICAL TRIALS\",\"volume\":\"117 18 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"B14. LATE BREAKING CLINICAL TRIALS\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/AJRCCM-CONFERENCE.2019.199.1_MEETINGABSTRACTS.A7359\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"B14. LATE BREAKING CLINICAL TRIALS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/AJRCCM-CONFERENCE.2019.199.1_MEETINGABSTRACTS.A7359","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Sustainability and Durability of Culture Conversion in Patients Receiving Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Mycobacterium Avium Complex Lung Disease (MAC-LD) in the CONVERT Study